Indication
nosocomial pneumonia
4 clinical trials
6 products
Product
Ceftolozane/TazobactamClinical trial
A Phase 1, Open-label, Non-comparative, Multicenter Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Ceftolozane/Tazobactam (MK-7625A) in Pediatric Participants With Nosocomial PneumoniaStatus: Recruiting, Estimated PCD: 2025-09-22
Clinical trial
The Effectiveness of Adding Multiple Intermittent High-dose Inhalations of Nitric Oxide to Standard Antibacterial Therapy in the Treatment of PneumoniaStatus: Recruiting, Estimated PCD: 2026-01-15
Product
Nitric OxideProduct
ShamClinical trial
High-dose Inhaled NO Therapy for the Prevention of Nosocomial Pneumonia After Cardiac Surgery With Cardiopulmonary BypassStatus: Completed, Estimated PCD: 2024-01-15
Product
Sham treatmentProduct
200- ppm NOClinical trial
Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of CareStatus: Completed, Estimated PCD: 2019-11-01
Product
POPS